Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05899140 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial

Study acronym: SoTiClin
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated December 9, 2024 (before its estimated March 29, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv4 Show 4 more changesShow less
    • Primary completion date: Mar 29, 2024 to Mar 29, 2026
    • Study sites: 0 to 1
    • Study completion date: Jul 31, 2024 to Jul 31, 2026
    • Start date changed from estimate of Feb 1, 2024 to Mar 15, 2024
  2. Start date: Aug 1, 2023 to Feb 1, 2024v3
  3. Study description shortened, about 252 wordsv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is an exploratory study to evaluate the effect of adjunctive clindamycin in the treatment of skin and soft-tissue infections due to Staphylococcus aureus in patients from Sierra Leone. The study hypothesizes that clindamycin, when added to routine treatment, will lead to a more rapid clinical resolution and less frequent recurrences of infection.
Trial Details
NCT Number NCT05899140
Lead Sponsor Frieder Schaumburg
Conditions
(from sponsor)		 Skin Infection, Staphylococcal Infections, Staphylococcus Aureus Infection
Related terms Cellulitis, Staphylococcal Infections
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov